Updates on the Treatment of Epilepsy in Women

William O. Tatum IV, Joyce Liporace, Selim R. Benbadis, Peter W Kaplan

Research output: Contribution to journalArticle

Abstract

Epilepsy is a condition of the central nervous system that is characterized by recurrent seizures. The goal of management is to make patients seizure free without intolerable adverse effects from treatment. Men and women differ in their physiologic makeup and therefore have different needs that must be considered when attempting to attain this goal. There are special concerns for women of child-bearing years with regard to contraception, pregnancy, and teratogenicity that should be consided during counseling and selection of appropriate treatment. There are also emerging concerns about the interaction of antiepileptic drugs and endocrine function that can affect ovarian function, induce polycystic ovary (PCO)-like syndrome, and threaten fertility. Systemic adverse effects can have a negative impact on weight, cosmetic appearance, sexual function, and bone health. Individualized treatment coupling antiepileptic drug use and the specific phase of impact of the reproductive cycle must be considered in treatment selection. Important concerns regarding long-term therapy are being raised as there are more treatment options to consider because of the plethora of new antiepileptic drugs that are available, often with more favorable pharmacokinetics and different adverse event profiles. Also, sex hormone fluctuations during maturation may exacerbate seizures at particular points during the life cycle for women, including menarche, during menses, during pregnancy, or later in the perimenopausal years, often presenting a uniquely challenging aspect to treatment. As the number of available treatment options for epilepsy increases, the optimal goal for primary care physicians is to work as a team with obstetricians, gynecologists, and neurologists in an effort to ensure the best treatment of women with epilepsy.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalArchives of Internal Medicine
Volume164
Issue number2
DOIs
StatePublished - Jan 26 2004

Fingerprint

Epilepsy
Anticonvulsants
Seizures
Therapeutics
Pregnancy
Menarche
Menstruation
Polycystic Ovary Syndrome
Gonadal Steroid Hormones
Primary Care Physicians
Life Cycle Stages
Contraception
Cosmetics
Fertility
Counseling
Central Nervous System
Pharmacokinetics
Weights and Measures
Bone and Bones
Health

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Updates on the Treatment of Epilepsy in Women. / Tatum IV, William O.; Liporace, Joyce; Benbadis, Selim R.; Kaplan, Peter W.

In: Archives of Internal Medicine, Vol. 164, No. 2, 26.01.2004, p. 137-145.

Research output: Contribution to journalArticle

Tatum IV, William O. ; Liporace, Joyce ; Benbadis, Selim R. ; Kaplan, Peter W. / Updates on the Treatment of Epilepsy in Women. In: Archives of Internal Medicine. 2004 ; Vol. 164, No. 2. pp. 137-145.
@article{baec099671954011814565438da7eff4,
title = "Updates on the Treatment of Epilepsy in Women",
abstract = "Epilepsy is a condition of the central nervous system that is characterized by recurrent seizures. The goal of management is to make patients seizure free without intolerable adverse effects from treatment. Men and women differ in their physiologic makeup and therefore have different needs that must be considered when attempting to attain this goal. There are special concerns for women of child-bearing years with regard to contraception, pregnancy, and teratogenicity that should be consided during counseling and selection of appropriate treatment. There are also emerging concerns about the interaction of antiepileptic drugs and endocrine function that can affect ovarian function, induce polycystic ovary (PCO)-like syndrome, and threaten fertility. Systemic adverse effects can have a negative impact on weight, cosmetic appearance, sexual function, and bone health. Individualized treatment coupling antiepileptic drug use and the specific phase of impact of the reproductive cycle must be considered in treatment selection. Important concerns regarding long-term therapy are being raised as there are more treatment options to consider because of the plethora of new antiepileptic drugs that are available, often with more favorable pharmacokinetics and different adverse event profiles. Also, sex hormone fluctuations during maturation may exacerbate seizures at particular points during the life cycle for women, including menarche, during menses, during pregnancy, or later in the perimenopausal years, often presenting a uniquely challenging aspect to treatment. As the number of available treatment options for epilepsy increases, the optimal goal for primary care physicians is to work as a team with obstetricians, gynecologists, and neurologists in an effort to ensure the best treatment of women with epilepsy.",
author = "{Tatum IV}, {William O.} and Joyce Liporace and Benbadis, {Selim R.} and Kaplan, {Peter W}",
year = "2004",
month = "1",
day = "26",
doi = "10.1001/archinte.164.2.137",
language = "English (US)",
volume = "164",
pages = "137--145",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Updates on the Treatment of Epilepsy in Women

AU - Tatum IV, William O.

AU - Liporace, Joyce

AU - Benbadis, Selim R.

AU - Kaplan, Peter W

PY - 2004/1/26

Y1 - 2004/1/26

N2 - Epilepsy is a condition of the central nervous system that is characterized by recurrent seizures. The goal of management is to make patients seizure free without intolerable adverse effects from treatment. Men and women differ in their physiologic makeup and therefore have different needs that must be considered when attempting to attain this goal. There are special concerns for women of child-bearing years with regard to contraception, pregnancy, and teratogenicity that should be consided during counseling and selection of appropriate treatment. There are also emerging concerns about the interaction of antiepileptic drugs and endocrine function that can affect ovarian function, induce polycystic ovary (PCO)-like syndrome, and threaten fertility. Systemic adverse effects can have a negative impact on weight, cosmetic appearance, sexual function, and bone health. Individualized treatment coupling antiepileptic drug use and the specific phase of impact of the reproductive cycle must be considered in treatment selection. Important concerns regarding long-term therapy are being raised as there are more treatment options to consider because of the plethora of new antiepileptic drugs that are available, often with more favorable pharmacokinetics and different adverse event profiles. Also, sex hormone fluctuations during maturation may exacerbate seizures at particular points during the life cycle for women, including menarche, during menses, during pregnancy, or later in the perimenopausal years, often presenting a uniquely challenging aspect to treatment. As the number of available treatment options for epilepsy increases, the optimal goal for primary care physicians is to work as a team with obstetricians, gynecologists, and neurologists in an effort to ensure the best treatment of women with epilepsy.

AB - Epilepsy is a condition of the central nervous system that is characterized by recurrent seizures. The goal of management is to make patients seizure free without intolerable adverse effects from treatment. Men and women differ in their physiologic makeup and therefore have different needs that must be considered when attempting to attain this goal. There are special concerns for women of child-bearing years with regard to contraception, pregnancy, and teratogenicity that should be consided during counseling and selection of appropriate treatment. There are also emerging concerns about the interaction of antiepileptic drugs and endocrine function that can affect ovarian function, induce polycystic ovary (PCO)-like syndrome, and threaten fertility. Systemic adverse effects can have a negative impact on weight, cosmetic appearance, sexual function, and bone health. Individualized treatment coupling antiepileptic drug use and the specific phase of impact of the reproductive cycle must be considered in treatment selection. Important concerns regarding long-term therapy are being raised as there are more treatment options to consider because of the plethora of new antiepileptic drugs that are available, often with more favorable pharmacokinetics and different adverse event profiles. Also, sex hormone fluctuations during maturation may exacerbate seizures at particular points during the life cycle for women, including menarche, during menses, during pregnancy, or later in the perimenopausal years, often presenting a uniquely challenging aspect to treatment. As the number of available treatment options for epilepsy increases, the optimal goal for primary care physicians is to work as a team with obstetricians, gynecologists, and neurologists in an effort to ensure the best treatment of women with epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=0942287304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942287304&partnerID=8YFLogxK

U2 - 10.1001/archinte.164.2.137

DO - 10.1001/archinte.164.2.137

M3 - Article

C2 - 14744836

AN - SCOPUS:0942287304

VL - 164

SP - 137

EP - 145

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 2

ER -